Boston Scientific shares rose 4.9% this morning to a price of $96.46. The stock is still trading within range of its average target price of $99.78, and over the last 52 weeks, it has recorded a 54.6% performance. Analysts have given the Large-Cap Medical Instruments & Supplies stock target prices ranging from $83.0 to $116.0 dollars per share, with an average rating of buy.
The stock has a very low short interest at 0.8%, and a short ratio of 2.51. The company's insiders own 0.18% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 92.4% of Boston Scientific's shares being owned by this investor type.
Institutions Invested in Boston Scientific
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-09-30 | FMR, LLC | 9% | 135,196,894 | $13,041,092,271 |
| 2024-09-30 | Vanguard Group Inc | 9% | 131,290,722 | $12,664,302,923 |
| 2024-09-30 | Blackrock Inc. | 9% | 128,700,760 | $12,414,475,191 |
| 2024-09-30 | State Street Corporation | 4% | 62,846,328 | $6,062,156,741 |
| 2024-09-30 | Primecap Management Company | 3% | 37,826,500 | $3,648,744,155 |
| 2024-09-30 | Wellington Management Group, LLP | 2% | 32,820,828 | $3,165,897,038 |
| 2024-09-30 | Geode Capital Management, LLC | 2% | 29,584,841 | $2,853,753,735 |
| 2024-09-30 | Bank of America Corporation | 2% | 28,148,659 | $2,715,219,621 |
| 2024-09-30 | JP Morgan Chase & Company | 2% | 26,039,392 | $2,511,759,728 |
| 2024-09-30 | Massachusetts Financial Services Co. | 2% | 25,667,693 | $2,475,905,643 |
Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Boston Scientific.
